Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2771-2784
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2771
Figure 1 Flow diagram of the study protocol.
NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease.
- Citation: Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, Cheng GH, Liu P, Sun MY. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(15): 2771-2784
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2771.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2771